Health in Tech, INC Form 4 insider transactions

Sanjay K Shrestha, Chief Executive Officer and a Director of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Tim Donald Johnson, Executive Chairman, a Director and 10% owner of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., sold 1,667 shares of common stock on November 3, 2026 for $0.55 per share.

Sanjay K Shrestha, Chief Executive Officer and a Director of Health In Tech, Inc., reported multiple transactions in common stock on October 20, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 119,728 shares of common stock on October 15, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., sold 3,333 shares of common stock on October 15, 2026 for $0.62 per share.

Linlin Qian, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 47,516 shares of common stock on October 15, 2026.

Timothy Hayes, a Director of Health In Tech, Inc., received 26,301 shares of common stock on October 7, 2026.

William D. Howard, a Director of Health In Tech, Inc., received 26,301 shares of common stock on October 7, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,795 shares of common stock on September 15, 2026.

Linlin Qian, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 33,725 shares of common stock on September 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 63,339 shares of common stock on September 15, 2026.

Timothy Hayes, a Director of Health In Tech, Inc., sold 12,000 shares of common stock on September 14, 2026 for $0.89 per share.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., sold 11,667 shares of common stock on September 11, 2026 for $0.92 per share.

Timothy Hayes, a Director of Health In Tech, Inc., sold 17,730 shares of common stock on September 9, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,183 shares of common stock on August 13, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 46,327 shares of common stock on August 13, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,007 shares of common stock on August 13, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,084 shares of common stock on July 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 47,217 shares of common stock on July 15, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,725 shares of common stock on July 15, 2026.

Health In Tech, Inc. director Sanjay K. Shrestha has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech, Inc. director William D. Howard has executed a Power of Attorney authorizing specific individuals to handle SEC filings related to securities ownership and transactions.

Health In Tech, Inc. director Timothy Hayes has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech's Chief Growth Officer, Zain Hasan, reported a transaction involving the surrender of restricted shares to cover tax obligations.

Health In Tech CEO Tim Johnson reported a transaction involving the surrender of restricted shares to cover tax obligations, impacting his direct beneficial ownership.

Health In Tech's Chief Financial Officer, LinLin Qian, has reported transactions involving Class A Common Stock, including the surrender of shares for tax withholding.

Chief Strategy Officer Jonathan Del Lockett was granted 50,000 restricted shares of Class A Common Stock tied to performance milestones.

CFO LinLin Qian surrendered 23,324 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.